Back
T-Mobile US Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
72
TMUS
T-Mobile US
Last Price:
177.67
Seasonality Move:
0.73%
Sell
35
RARE
Ultragenyx Pharmaceutical
Last Price:
37.44
Seasonality Move:
3.65%
Buy
72
T-Mobile US (TMUS)
is a Buy
Is T-Mobile US a Buy, Sell or Hold?
- The current T-Mobile US [TMUS] share price is $177.61. The Score for TMUS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- TMUS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TMUS Stock Price Chart
What is T-Mobile US's stock price today?
-
The T-Mobile US share price today is $177.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TMUS is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $37.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.
TMUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.24 | Buy |
Relative Strength Index (14 RSI): | 63.82 | Buy |
Chaikin Money Flow: | 2971323 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (165.14 - 178) | Buy |
Bollinger Bands (100): | (159.57 - 170.05) | Buy |
RARE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.58 | Sell |
Relative Strength Index (14 RSI): | 37.74 | Sell |
Chaikin Money Flow: | -836354 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.26 - 42.36) | Sell |
Bollinger Bands (100): | (41.26 - 48.86) | Sell |
TMUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 177.35 | Buy |
20-day SMA: | 173.63 | Buy |
50-day SMA: | 167.1 | Buy |
200-day SMA: | 156.86 | Buy |
8-day EMA: | 176.71 | Buy |
20-day EMA: | 173.99 | Buy |
50-day EMA: | 169.22 | Buy |
200-day EMA: | 158.94 | Buy |
RARE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.11 | Sell |
20-day SMA: | 40.61 | Sell |
50-day SMA: | 42.43 | Sell |
200-day SMA: | 42.45 | Sell |
8-day EMA: | 40.32 | Sell |
20-day EMA: | 40.92 | Sell |
50-day EMA: | 42.29 | Sell |
200-day EMA: | 43.55 | Sell |
T-Mobile US Earnings Growth & TMUS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.38 per share, an increase this year of $1.53 per share, and an increase next year of $1.94 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
T-Mobile US Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ultragenyx Pharmaceutical Technical Analysis
Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |